Who are Rectifypharma's investors?

Rectifypharma's investors include Atlas Venture, DC Investment Partners, Longwood Fund, Forbion.

Rectifypharma

Founded 2020 · 22 employees on LinkedIn · 4 known investors

Find your way into Rectifypharma

316 people in our graph share verified history with the Rectifypharma team — schools, employers, funds. One of them is your warm intro.

Samantha Truexunlockedknows Rajesh Devraj · together at Padlock Therapeutics Inc. (overlapped)

knows the team · via Deciphera Pharmaceuticals

×10knows the team · via Searle Discovery Research, Monsanto Life Sciences, Co.

Rectify Pharma is a biotechnology company developing therapies, with a pipeline that has included work in liver and metabolic disease areas. This page profiles a member of its executive team.

Biotech Deep Tech

Founders & leadership

Rajesh Devraj President and Chief Executive OfficerVenture Partner at Atlas Venture

Robert HughesChief Scientific Officer

Pol BoudesChief Medical Officer

Investors · 4

Atlas Venture✓ confirmed by RectifypharmaCambridge · $500K – $1M

How we know: Atlas Venture's portfolio page · the company's own site · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

DC Investment Partnerslisted by DC Investment PartnersMcLean · $10M

How we know: DC Investment Partners's portfolio page · Not right? Tell us

Longwood Fundlisted by Longwood FundBoston

How we know: Longwood Fund's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

ForbionreportedNaarden

How we know: a partner's Signal profile · Not right? Tell us

Founder mafia

3 people who came through Rectifypharma went on to found or lead other companies.

David SteinbergBoard MemberFounded Restorbio +3 Jason RhodesExecutive Chair (and founding CEO)Founded Dyne Therapeutics Jodie MorrisonMember Board of DirectorsFounded Q32 Bio

Frequently asked questions

What does Rectifypharma do?: Rectify Pharma is a biotechnology company developing therapies, with a pipeline that has included work in liver and metabolic disease areas. This page profiles a member of its executive team.
Who are Rectifypharma's investors?: Rectifypharma's investors include Atlas Venture, DC Investment Partners, Longwood Fund, Forbion.